Filing metadata

Accession number
0000950170-25-015362
Form type
Form 4
Filer
Revance Therapeutics, Inc.
CIK
CIK 1479290
Filed
Feb 06, 2025
Reporting period
Feb 04, 2025
Description
Insider transaction

Explore SEC Filings Hub